| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2944815 | Journal of the American College of Cardiology | 2014 | 11 Pages |
Abstract
Patients undergoing TAVR based solely on TI have better survival and quality of life improvements than those who are inoperable due to clinical comorbidities. Both TI and CLI TAVR have significant survival benefit in the context of standard therapy. (THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial; NCT00530894)
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Raj R. MD, Hasan MD, Michael MD, Tarun MD, David J. MD, MSc, Wen MD, Gregory P. MD, Joseph E. MD, Vinod H. MD, Howard C. MD, Augusto MD, Samir MD, Vasilis MD, Brian K. MD, Susheel K. MD, Mathew MD, Alfredo MD, Craig R. MD, Martin B. MD,